Back

Age-dependent prognostic significance of metabolic markers and comorbidities in sarcoidosis: a cohort study of 707 patients

28 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Cardiovascular risk in immune-mediated and multisystem disorders: new predictors and clinical outcomes Autoimmune/Chronic Inflammatory Disorders and Heart Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Elias Gialafos

University of Athens, Athens (Greece)

5 More presentations in this session

Presentation thumbnail
Prognostic impact of antiphospholipid antibodies in acute coronary syndrome
Doctor Y. Ishii (Yokohama, JP)
Abstract Slides Video
Presentation thumbnail
Traditional risk factors underestimate cardiovascular risk in individuals with coeliac disease in the Trondelag Health Study (HUNT4)
Doctor S. Zuehlke (Namsos, NO)
Abstract Slides Video
Presentation thumbnail
Clinical predictors for ventricular arrhythmia and heart failure hospitalisation in cardiac sarcoidosis
Doctor V. Rossi (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes of initial steroid pulse therapy in cardiac sarcoidosis: a nationwide multicenter study from the MYSTICS registry
Doctor K. Shimamoto (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
Aortic stiffness and cardiac inflammation, fibrosis, and diastolic dysfunction in post-COVID-19 patients
Doctor A. Klement (DE)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular risk in immune-mediated and multisystem disorders: new predictors and clinical outcomes

The Event

Event poster

ESC Congress 2026

28 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Epidemiology of long-term mortality and cardiovascular events in cardiac sarcoidosis
30 August 2026
thumbnail
Congress Presentation
A plasma metabolite profile predicts worsening of heart failure and reflects distinct inflammatory mechanisms in symptomatic heart failure
28 August 2026
thumbnail
Congress Presentation
Apolipoprotein E4 as a genetic biomarker of mortality in patients with dilated cardiomyopathy
28 August 2026
thumbnail
Congress Presentation
Elevated lipoprotein(a) and progression of aortic stenosis: a systematic review and meta-analysis of cardiovascular outcomes
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources